Argantrix Limited

Active08928132 Private limited company
Incorporated
7 March 2014 (12 years)
Industry
Other professional, scientific and technical activities n.e.c. (74909)
Accounts type
Micro entity
Region
South East
Address
Orchard Lea Horns Lane
Combe
Witney
OX29 8NH

Filing status

Accounts due
31 December 2026
Last accounts
31 March 2025
Conf. stmt due
21 March 2027
Last conf. stmt
7 March 2026

Officers 3 active

Officer details are public data from the Companies House register.

Director · Appointed 9 March 2023
Also at Strawman Limited, Cholestenix Limited (proposed for strike-off), Estryx Pharma Limited (proposed for strike-off) · more companies
British
Born October 1962 (64)
Normanton, John Raymond, Dr
Secretary · Appointed 7 March 2014
Director · Appointed 7 March 2014
Also at Cholestenix Limited (proposed for strike-off), Estryx Pharma Limited (proposed for strike-off), Oxandia Ltd · more companies
British
Born October 1954 (72)
Officer history (1 former)
9 March 2023
Appointed Normanton, Trudy as Director
9 March 2023
Resigned Sopwith, Thomas Anthony Edward as Director
7 March 2014
Appointed Normanton, John Raymond, Dr as Secretary
7 March 2014
Appointed Normanton, John Raymond, Dr as Director
7 March 2014
Appointed Sopwith, Thomas Anthony Edward as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2016
Owns 50–75% of shares
Holds 50–75% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 5767040
Former controllers (1)
8 March 2020
Ceased Thomas Anthony Edward Sopwith — Owns 25–50% of shares

Group structure 7 companies

Ownership group derived from the Companies House PSC register

Argantrix Limited This company Owns 50–75% of shares
Cholestenix Limited Proposed for strike-offHolds 75–100% of voting rights
Estryx Pharma Limited Proposed for strike-offOwns 25–50% of shares
Gliagenesis Limited Owns 25–50% of shares
Ipgenix Limited Owns 75–100% of shares
Nebuquine Limited Holds 75–100% of voting rights

Financials

Balance sheet as at 31 March 2025 · micro entity accounts

Net Assets
(£5,040)
Debt Ratio
1894%
Current Ratio
0.1x

Trend

Net Assets
(£15k) (£10k) (£5k) £0 2021 2022 2023 2025 (£12,643) (£14,796) (£14,425) (£5,040)
Balance sheet detail
202520242023202220212020
Fixed Assets£6£6£6£32
Current Assets£275£93£49£134£406£89
Debtors£20£332£79
Cash£29£38£74£10
Creditors (< 1 year)£5,321£2,883£14,962£13,081£12,776
Net Current Assets(£5,046)(£14,431)(£14,828)(£12,675)(£12,687)
Net Assets(£5,040)(£14,425)(£14,796)(£12,643)
Shareholder Funds(£5,040)(£2,784)(£14,796)(£12,643)(£12,655)

What Argantrix say about themselves

“ArgantriX provides technology transfer services to start-up companies engaged in international scientific collaborations.”

— from argantrix.com

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
31 March 2026Confirmation statement with no updates7 March 2026
18 December 2025Micro company accounts31 March 2025
11 March 2025Confirmation statement with no updates7 March 2025
20 December 2024Micro company accounts31 March 2024
13 March 2024Confirmation statement with no updates7 March 2024
Show all recent filings

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?